Penhoat A, Jaillard C, Crozat A, Saez J M
Institut National de la Santé et de la Recherche Médicale Unité 307, Hôpital Debrousse, Lyon.
Eur J Biochem. 1988 Feb 15;172(1):247-54. doi: 10.1111/j.1432-1033.1988.tb13880.x.
The aim of the present study was to investigate the effect of several effectors on angiotensin II (A-II) receptors and steroidogenic responsiveness in cultured bovine fasciculata cells. Treatment of adrenal cells for 24 h with A-II (0.1 microM), corticotropin (1 nM), phorbol ester (PMA 0.1 microM), calcium ionophore A23187 (0.1 microM) and cyclic 8-bromoAMP (1 mM) produced a loss of A-II receptors whereas the A-II antagonist [Sar1-Ala8]A-II (0.1 microM) led to a small but significant increase. The extent of the down-regulation of receptors following maximal concentrations of A-II was greater than that produced by the other agents. The effects of A-II were dose-dependent with a ID50 of 3 nM. Since cycloheximide and actinomycin blocked the down-regulation of receptors, it seems likely that the effectors lead to the synthesis of certain proteins which inhibit the recycling of internalized receptors. Pretreatment of adrenal cells with A-II induced both homologous (90% decrease) and heterologous (corticotropin 83, PMA and ionophore 76% decrease) steroidogenic desensitization. However, the cAMP response to corticotropin of A-II-pretreated cells was higher (P less than 0.001) than for control cells. Pretreatment with PMA and A23187 also resulted in both homologous and heterologous steroidogenic refractoriness but to a lesser degree than that induced by A-II. In contrast, corticotropin-pretreated cells responded normally to further stimulation with corticotropin or A-II. Similarly pretreatment of bovine adrenal glomerulosa cells with A-II (1 nM and 0.1 microM) and corticotropin (1 nM) also induced A-II receptor loss and steroidogenic refractoriness. The present findings indicate that, in contrast to the results reported in vivo in the rat, where A-II leads to up-regulation of its own receptors on glomerulosa cells and increases steroidogenic responsiveness, this peptide results in both down-regulation and desensitization in cultured bovine fasciculata and glomerulosa cells. Our results also emphasize the absence of correlation between A-II receptor loss and steroidogenic responsiveness.
本研究的目的是调查几种效应物对培养的牛束状带细胞中血管紧张素II(A-II)受体和类固醇生成反应性的影响。用A-II(0.1微摩尔)、促肾上腺皮质激素(1纳摩尔)、佛波酯(PMA 0.1微摩尔)、钙离子载体A23187(0.1微摩尔)和环8-溴腺苷酸(1毫摩尔)处理肾上腺细胞24小时会导致A-II受体丧失,而A-II拮抗剂[Sar1-Ala8]A-II(0.1微摩尔)则导致小幅但显著的增加。最大浓度的A-II作用后受体下调的程度大于其他试剂所产生的程度。A-II的作用呈剂量依赖性,半数抑制浓度为3纳摩尔。由于环己酰亚胺和放线菌素阻断了受体的下调,效应物似乎可能导致某些蛋白质的合成,这些蛋白质抑制内化受体的再循环。用A-II预处理肾上腺细胞会诱导同源(降低90%)和异源(促肾上腺皮质激素降低83%,PMA和离子载体降低76%)类固醇生成脱敏。然而,A-II预处理细胞对促肾上腺皮质激素的cAMP反应高于对照细胞(P<0.001)。用PMA和A23187预处理也会导致同源和异源类固醇生成不应性,但程度低于A-II诱导的程度。相反,促肾上腺皮质激素预处理的细胞对促肾上腺皮质激素或A-II的进一步刺激反应正常。同样,用A-II(1纳摩尔和0.1微摩尔)和促肾上腺皮质激素(1纳摩尔)预处理牛肾上腺球状带细胞也会诱导A-II受体丧失和类固醇生成不应性。目前的研究结果表明,与大鼠体内报道的结果相反,在大鼠体内A-II导致其自身在球状带细胞上的受体上调并增加类固醇生成反应性,而在培养的牛束状带和球状带细胞中,这种肽会导致下调和脱敏。我们的结果还强调了A-II受体丧失与类固醇生成反应性之间不存在相关性。